We've tested the top AI image generation apps to help you find the one that produces the best results for the lowest price. I’ve been writing about consumer technology and video games for more than a ...

Learning to program in C on an online platform can provide structured learning and a certification to show along with your resume. Learning C can still be useful in 2026, especially if you want to ...

STERLING, Va. — Not long after the enormous data center sprouted in Jessica Medeiros’s residential neighborhood, she began seeing black smoke. “There are times when the generators are running and … ...

The NFL Draft is set for April 23-25, but attention is already beginning to shift to 2027 and its quarterback class. Five signal-callers are emerging as early names to watch, with some analysts ...

In the era of A.I. agents, many Silicon Valley programmers are now barely programming. Instead, what they’re doing is deeply, deeply weird. Credit...Illustration by Pablo Delcan and Danielle Del Plato ...

One week after he was involved in a terrible elevator accident in South Africa, Italian pro golfer Andrea Pavan was released from a hospital on Wednesday. In an Instagram post that included a picture ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

A two-time DP World Tour winner suffered a serious—and freak—off-course injury ahead of this week's Investec South African Open. According to Monday Q Info's Ryan French, Andrea Pavan was badly ...

Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...